Mark Your Calendar For CDTX Data, VRX Inks Deal, VTVT On STEADFAST Watch

Today's Daily Dose brings you news about the anticipated milestones of Cidara and vTv Therapeutics; Valeant Pharma's deal with Japan-based Kaken Pharmaceutical, and Horizon Pharma seeking FDA approval for expanded indication of RAVICTI.

from RTT - Top Story http://ift.tt/2GPaGLD
via IFTTT

Comments